Completed
Efficacy and Safety of Activated Recombinant Human Factor VII in Refractory Haemorrhagic Cystitis
NCT01561352
- Conditions
- Cystitis, Cystitis, Hemorrhagic, Female Urogenital Diseases, +7 more
- Locations
-
- Novo Nordisk Investigational Site Chapel Hill, North Carolina, United States
- Novo Nordisk Investigational Site Chapel Hill, North Carolina, United States
- Novo Nordisk Investigational Site Houston, Texas, United States